BRAFTOVI ENCORAFENIB CAPSULES
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jul 2024)
What this means for you
Registered since 11 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87756187
- Registration number
- 5625743
- Mark type
- Design + words
- Filed
- 16 Jan 2018
- Published for opposition
- 25 Sept 2018
- Registered
- 11 Dec 2018
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use;] Pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma ]
Owner
- Array Biopharma Inc., Boulder, CO, US
- Array Biopharma Inc., Boulder, CO, US
- Array Biopharma Inc., Boulder, CO, US
Prosecution history
- 13 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jul 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 11 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Nov 2020 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 16 Nov 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Jul 2020 — TEAS SECTION 7 REQUEST RECEIVED
- 04 Jun 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Jun 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Jun 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Jun 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Jun 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 25 Sept 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED